Financial Burden, Out-of-Pocket Health Spending, and Household Economic Well-Being in Heart Failure Patients in India: A Multicentre Cross-Sectional Survey
Panniyammakal Jeemon, Reethu Salim, K. Safvan, Greeva Philip, Aditya Kapoor, Amir Rashid, Ajay Bahl, Animesh Mishra, Bhavesh Roy, Bishav Mohan, Dinesh Choudhary, Jabir Abdullakutty, Justin Paul, Jayesh Prajapati, Neelam Dahiya, Prakash C. Negi, Rishi Sethi, Satyanarayan Routray

TL;DR
Heart failure patients in India face high out-of-pocket health costs, leading to economic hardship, especially among those without health insurance.
Contribution
This study quantifies the financial burden and economic impact of heart failure management in India, highlighting disparities between insured and uninsured patients.
Findings
Average out-of-pocket health spending constitutes 92.6% of total health expenditure for heart failure patients in India.
Catastrophic health spending and distress financing are significantly lower among insured patients compared to uninsured ones.
Over 30% of households report a decline in monthly income due to heart failure-related expenses.
Abstract
Heart failure (HF) is a complex clinical condition requiring resource-intensive management and substantial health expenditure. The adverse economic impact of medical care on patients or financial burden is increasingly recognised as a significant non-clinical entity affecting HF management in low- and middle-income countries (LMIC). We explored the factors associated with Financial Burden (FB) in HF patients in India. We recruited HF patients from 21 hospitals across India, selected to reflect regional diversity and varying stages of epidemiological transition. Trained personnel collected clinical and economic data using a validated and structured questionnaire. Expenditures were recorded in Indian rupees (INR) and converted to international dollars (INT$). We recruited 1,859 participants. Nearly one-third of participants (30.2%) were women. The mean age was 55.9 (11.3) years, and the…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHealthcare Systems and Reforms · Heart Failure Treatment and Management · Health Systems, Economic Evaluations, Quality of Life
